"role of imaging based biomarkers in nafld: is biopsy still necessary?"
Published 6 years ago • 1K plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
3:46
"non-invasive assessment of non-alcoholic fatty liver disease....."
-
2:26
journal of hepatology - nafld special issue
-
2:57
clinical practice update on noninvasive biomarkers in nafld/masld
-
25:40
the importance of non-invasive screening in nafld
-
1:59
journal of hepatology - nafld special issue
-
0:48
noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease... | rtcl.tv
-
27:51
ck18 as a biomarker in nash clinical trials
-
1:03:15
a proteomics signature of nash
-
31:03
nonalcoholic fatty liver disease | jihane n. benhammou, md, phd | ucla digestive diseases
-
20:59
integrating non-invasive tests for nafld in clinical practice outside the liver space - alina allen
-
18:43
the fontan liver: a hepatologist's perspective - dr. rob venick | 2017 ucla achd symposium
-
0:42
reduce fatty liver by 50 percent!
-
5:16
nafld, alcohol, and heart disease
-
59:44
nonalcoholic fatty liver disease and cardiovascular risk
-
28:34
mre for nafld and nash clinical trials
-
3:01:30
iria webinar on preventing nafld & nash-risk stratification with elastography in fatty liver disease
-
4:08:18
use of biomarkers for diagnosing and assessing treatment response in noncirrhotic nash trials-d1-am
-
53:04
"nafld and nash" by stanley martin cohen md, faasld, facg